Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes

Approximately 10% to 15% of human cancers lack detectable telomerase activity, and a subset of these maintain telomere lengths by the telomerase-independent telomere maintenance mechanism termed alternative lengthening of telomeres (ALT). The ALT phenotype, relatively common in subtypes of sarcomas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Heaphy, Christopher M., Subhawong, Andrea P., Hong, Seung-Mo, Goggins, Michael G., Montgomery, Elizabeth A., Gabrielson, Edward, Netto, George J., Epstein, Jonathan I., Lotan, Tamara L., Westra, William H., Shih, Ie-Ming, Iacobuzio-Donahue, Christine A., Maitra, Anirban, Li, Qing K., Eberhart, Charles G., Taube, Janis M., Rakheja, Dinesh, Kurman, Robert J., Wu, T.C., Roden, Richard B., Argani, Pedram, De Marzo, Angelo M., Terracciano, Luigi, Torbenson, Michael, Meeker, Alan K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Investigative Pathology 2011
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3181356/
https://ncbi.nlm.nih.gov/pubmed/21888887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajpath.2011.06.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados